Cargando…

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status

BACKGROUND: Reading difficulties are commonly reported in Parkinson's disease (PD). So far, only a few studies have assessed reading in PD, most of them confirming a different pattern in patients compared with healthy populations. Impaired oculomotor control is an early feature of PD. Cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsitsi, Panagiota, Nilsson, Mattias, Seimyr, Gustaf Öqvist, Larsson, Olof, Svenningsson, Per, Markaki, Ioanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105091/ https://www.ncbi.nlm.nih.gov/pubmed/37070064 http://dx.doi.org/10.1002/mdc3.13663

Ejemplares similares

Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Pupil light reflex dynamics in Parkinson’s disease
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Eye Movements during Reading and their Relationship to Reading Assessment Outcomes in Swedish Elementary School Children
por: Strandberg, Andrea, et al.
Publicado: (2022)

Screening for Dyslexia Using Eye Tracking during Reading
por: Nilsson Benfatto, Mattias, et al.
Publicado: (2016)

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
por: Green, Holly, et al.
Publicado: (2019)

Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
por: te Vruchte, Danielle, et al.
Publicado: (2022)

Slow fluctuations in eye position and resting-state functional magnetic resonance imaging brain activity during visual fixation
por: Fransson, Peter, et al.
Publicado: (2014)

Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson’s disease
por: Waldthaler, Josefine, et al.
Publicado: (2019)

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
por: Paslawski, Wojciech, et al.
Publicado: (2023)

Reduction of spontaneous cortical beta bursts in Parkinson’s disease is linked to symptom severity
por: Vinding, Mikkel C, et al.
Publicado: (2020)

Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017)

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
por: Svenningsson, Per, et al.
Publicado: (2018)

A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism
por: Papathoma, Paraskevi-Evita, et al.
Publicado: (2022)

Attenuated beta rebound to proprioceptive afferent feedback in Parkinson’s disease
por: Vinding, Mikkel C., et al.
Publicado: (2019)

Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
por: Bougea, Anastasia, et al.
Publicado: (2023)

Novel targeted therapies for Parkinson’s disease
por: Ntetsika, Theodora, et al.
Publicado: (2021)

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
por: Sundgren, Mathias, et al.
Publicado: (2021)

Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism
por: Monnot, Cyril, et al.
Publicado: (2017)

Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
por: Schintu, Nicoletta, et al.
Publicado: (2020)

GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson’s Disease Patients
por: Baek, Jean-Ha, et al.
Publicado: (2019)

MCEE Mutations in an Adult Patient with Parkinson’s Disease, Dementia, Stroke and Elevated Levels of Methylmalonic Acid
por: Andréasson, Mattias, et al.
Publicado: (2019)

Antidepressant-like properties of sarizotan in experimental Parkinsonism
por: Zhang, Xiaoqun, et al.
Publicado: (2011)

Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study
por: Larsson, Berit, et al.
Publicado: (2018)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018)

Altered CSF levels of monoamines in hereditary spastic paraparesis 10: A case series
por: Andréasson, Mattias, et al.
Publicado: (2019)

Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model
por: Kaya, Ibrahim, et al.
Publicado: (2023)

Impaired migratory phenotype of CD4(+) T cells in Parkinson’s disease
por: Mamula, Dejan, et al.
Publicado: (2022)

Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism
por: Sjöström, Henrik, et al.
Publicado: (2019)

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
por: Green, Holly F., et al.
Publicado: (2019)

Effect of Subthalamic Stimulation on Voice and Speech in Parkinson’s Disease: For the Better or Worse?
por: Skodda, Sabine, et al.
Publicado: (2014)

Cortex-wide topography of 1/f-exponent in Parkinson’s disease
por: Helson, Pascal, et al.
Publicado: (2023)

Immigrant Status Predicts Worse Subjective Memory Complaints
por: Franco, Yujin, et al.
Publicado: (2020)

24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
por: Björkhem, Ingemar, et al.
Publicado: (2018)

Genetically Targeted Clinical Trials in Parkinson’s Disease: Learning from the Successes Made in Oncology
por: Sjögren, Magnus, et al.
Publicado: (2021)

Worse and Worse and Worse: Essential Tremor Patients’ Longitudinal Perspectives on Their Condition
por: Gutierrez, Jesús, et al.
Publicado: (2016)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

Fluoxetine Suppresses Glutamate- and GABA-Mediated Neurotransmission by Altering SNARE Complex
por: Lazarevic, Vesna, et al.
Publicado: (2019)

Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease
por: Ran, Caroline, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q7jm33qoqps3fsv6658328resk